减少抗生素使用干预措施的报告质量阻碍抗菌药物耐药性循证决策:系统综述
本研究对近期系统综述中66项政府政策干预研究进行报告质量评估,使用SQUIRE 2.0清单18个条目。没有研究完整报告全部18个条目(中位得分10,IQR 8-11),仅20%的研究充分详细报告干预要素以供复制,仅24%报告干预预期作用机制。报告质量差距阻碍结果解读与复制,可能妨碍应对抗菌药物耐药性(AMR)的努力。
要点
- AMR干预研究普遍报告不完整,中位仅满足10/18条SQUIRE条目。
- 仅20%研究详细报告干预要素以支持复制,24%报告作用机制。
- 报告缺陷妨碍循证政策制定与未来评估。
核心结论
- AMR干预研究的报告质量存在显著差距,妨碍结果解读、复制及循证政策制定。
研究设计与样本
- 对近期一项关于减少人类抗菌药物使用的政府政策干预系统综述中66项研究进行描述性合成与比较分析,由两名评价者独立应用SQUIRE 2.0清单(18个条目)评估报告质量。
主要发现
- 没有研究完整报告全部18个SQUIRE条目,中位得分为10(IQR 8-11)。
- 各条目报告率从3%到100%不等。
- 仅20%的研究充分详细报告干预要素以供复制,仅24%报告干预预期作用机制。
关键数值与推荐
- SQUIRE 2.0清单包含18个条目,用于报告改善医疗保健的系统级干预。
临床怎么用
- 临床与政策制定者应谨慎解读AMR干预研究结果,并推动采用SQUIRE 2.0等标准改善报告以支持循证决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Countries are currently seeking evidence-informed policy options to address antimicrobial resistance (AMR). While rigorous evaluations of AMR interventions are the ideal, they are far from the current reality. Additionally, poor reporting and documentation of AMR interventions impede efforts to use evidence to inform future evaluations and policy interventions. OBJECTIVES: To critically evaluate reporting quality gaps in AMR intervention research. METHODS: To evaluate the reporting quality of studies, we conducted a descriptive synthesis and comparative analysis of studies that were included in a recent systematic review of government policy interventions aiming to reduce human antimicrobial use. Reporting quality was assessed using the SQUIRE 2.0 checklist of 18 items for reporting system-level interventions to improve healthcare. Two reviewers independently applied the checklist to 66 studies identified in the systematic review. RESULTS: None of the studies included complete information on all 18 SQUIRE items (median score = 10, IQR = 8-11). Reporting quality varied across SQUIRE items, with 3% to 100% of studies reporting the recommended information for each SQUIRE item. Only 20% of studies reported the elements of the intervention in sufficient detail for replication and only 24% reported the mechanism through which the intervention was expected to work. CONCLUSIONS: Gaps in the reporting of impact evaluations pose challenges for interpreting and replicating study results. Failure to improve reporting practice of policy evaluations is likely to impede efforts to tackle the growing health, social and economic threats posed by AMR.
引用
- Rogers Van Katwyk S, Grimshaw JM, Nkangu M, et al. Study reporting quality among interventions to reduce antibiotic use is a barrier to evidence-informed policymaking on antimicrobial resistance: systematic review. J Antimicrob Chemother. 2020. PMID: 31943008. doi:10.1093/jac/dkz540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。